Deciphera Pharmaceuticals, Inc.

Ownership Transactions Reported by 16 Insiders

Location
200 Smith Street, Waltham, MA

There are no Buy or Sell transactions made by insiders since 10/6/2024

Deciphera Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Brightstar Associates LLC 10%+ Owner $361M Apr 22, 2024
Daniel Lee Flynn Chief Scientific Officer $6.18M Jun 16, 2023
James Arthur Bristol Director $0 Jun 11, 2024
Dashyant Dhanak EVP & Chief Scientific Officer $0 Jun 11, 2024
Matthew L. Sherman EVP & Chief Medical Officer $0 Jun 11, 2024
Patricia L. Allen Director $0 Jun 11, 2024
Susan L. Kelley Director $0 Jun 11, 2024
Daniel C. Martin Chief Commercial Officer $0 Jun 11, 2024
Steven L. Hoerter President and CEO, Director $0 Jun 11, 2024
Ron Squarer Director $0 Jun 11, 2024
Edward J. Benz JR Director $0 Jun 11, 2024
John Richard Martin Director $0 Jun 11, 2024
Franklin Stuart Friedman Director $0 Jun 11, 2024
Dennis Leo Walsh Director $0 Jun 11, 2024
Thomas Patrick Kelly Chief Financial Officer $0 Jun 11, 2024
Jama Pitman SVP, Chief Development Officer $0 Jun 11, 2024

Recent Insider Transactions by Companies or Individuals for Deciphera Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.